{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:37:54Z","timestamp":1772793474006,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1476,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.jhep.2009.03.011","type":"journal-article","created":{"date-parts":[[2009,4,10]],"date-time":"2009-04-10T08:14:06Z","timestamp":1239351246000},"page":"8-10","source":"Crossref","is-referenced-by-count":12,"title":["Mycophenolate mofetil to the rescue in autoimmune hepatitis: A fresh sprout on the decision tree"],"prefix":"10.1016","volume":"51","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2009.03.011_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2001-13708","article-title":"Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience","volume":"39","author":"Kanzler","year":"2001","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhep.2009.03.011_bib2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2006.03104.x","article-title":"Type 1 autoimmune hepatitis: clinical course and outcome in an Italian multicentre study","volume":"24","author":"Floreani","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.03.011_bib3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1440-1746.2008.05365.x","article-title":"Favorable outcomes of autoimmune hepatitis in a community clinic setting","volume":"23","author":"Seo","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","article-title":"Rapidity of treatment response and outcome in type 1 autoimmune hepatitis","volume":"51","author":"Czaja","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.03.011_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jhep.2004.01.009","article-title":"Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis","volume":"40","author":"Czaja","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood. A 20 year survey","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.03.011_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1440-1746.2001.02492.x","article-title":"Autoimmune liver disease in children","volume":"16","author":"Yachha","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1440-1746.2001.02615.x","article-title":"Long-term outcome of autoimmune hepatitis in children","volume":"16","author":"Saadah","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: A 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.03.011_bib12","unstructured":"Czaja AJ. Features and consequences of untreated autoimmune hepatitis. Liver Int 2008 Oct 14. [Epub ahead of print]."},{"key":"10.1016\/j.jhep.2009.03.011_bib13","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/S0041-1345(99)00563-1","article-title":"Mycophenolate mofetil","volume":"31","author":"Becker","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2009.03.011_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jhep.2009.03.011_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007890-199908150-00014","article-title":"Mycophenolate acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines","volume":"68","author":"Cohn","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2009.03.011_bib16","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.165.5.2374","article-title":"Mycophenolate mofetil impairs the maturation and function of murine dendritic cells","volume":"165","author":"Mehling","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2009.03.011_bib17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.mcg.0000177260.72692.e8","article-title":"Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease","volume":"39","author":"Czaja","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2009.03.011_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy","volume":"18","author":"Devlin","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.03.011_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian Association for the Study of Liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","author":"Chatur","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.03.011_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","author":"Inductivo-Yu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib23","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.03.011_bib24","doi-asserted-by":"crossref","unstructured":"Wolf DC, Bojito L, Facciuto M, Lebovics E. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience. Dig Dis Sci, 2008 Dec 12 [Epub ahead of print].","DOI":"10.1007\/s10620-008-0632-0"},{"key":"10.1016\/j.jhep.2009.03.011_bib25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.1840110621","article-title":"Low dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis","volume":"11","author":"Czaja","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.03.011_bib26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.03.011_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1399-3046.1999.00015.x","article-title":"Mycophenolate mofetil-is it worth the cost? The in-favor opinion","volume":"3","author":"Seikaly","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jhep.2009.03.011_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14656566.7.2.145","article-title":"Cost-effectiveness of pharmacotherapy for autoimmune hepatitis","volume":"7","author":"Heneghan","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jhep.2009.03.011_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3899\/jrheum.080517","article-title":"Cost comparison between mycophenolate mofetil and cyclophoshamide-azathioprine in the treatment of lupus nephritis","volume":"36","author":"Tse","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jhep.2009.03.011_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2036.2004.02214.x","article-title":"A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of sclerosing cholangitis","volume":"20","author":"Sterling","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.03.011_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1572-0241.2005.40484.x","article-title":"Mycophenolate mofetil for the treatment of primary sclerosing cholangitis","volume":"100","author":"Talwalkar","year":"2005","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T11:55:01Z","timestamp":1558266901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827809002232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0168827809002232"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2009.03.011","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}